Synergen applies to market Antril in Europe

Synergen applies to market Antril in Europe

Synergen Inc. submitted an application to the Committee for Proprietary Medicinal Products for European marketing approval of Antril

Read the full 258 word article

How to gain access

Continue reading with a
two-week free trial.